• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Company Analysis - Forest Laboratories, Inc. Product Image

Company Analysis - Forest Laboratories, Inc.

  • Published: April 2011
  • Region: Global
  • 30 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Eli Lilly & Company
  • GlaxoSmithKline
  • Novo Nordisk A/S
  • MORE

Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.

The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.

The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.

Report Highlights

- Provides a comprehensive version of the company's performance

- Offers key financial data, ratio and SWOT analysis

- Tracks major M&A trends and developments

- Business Profile, SWOT analysis and financial information on top competitors

- View on the company by our analysts

- Supplemented with graphs and tabular information wherever necessary

1. Company Overview
1.1 History
1.2 Business Overview
1.3 Organizational Structure
1.4 Major Mergers & Acquisitions
1.5 Ticker Codes at various Stock Exchange Listings
1.6 Management Profile

2. Product & Services
2.1 Product & Services - An Overview
2.2 Revenue & Income Summary by Geographical Distribution
2.3 Revenue & Income Summary by Product

3. Financial Information for the Fiscal Year
3.1 Financial Summary for the Fiscal Year
3.2 Breakup of Revenue & Sales Trends
3.3 Ratio & Market Indicators
3.4 Earning & Income Estimates
3.5 Stock Analysis

4. SWOT Analysis
4.1 Strength
4.2 Weakness
4.3 Opportunity
4.4 Threats

5. Top Competitors (Key Financials & SWOT Analysis)
5.1 Novo Nordisk A/S
5.2 GlaxoSmithKline
5.3 Eli Lilly & Company

6. Analyst View

List of Tables:

Table 1-1: Forest Laboratories Inc. - Major Mergers & Acquisitions (1995 to 2011)
Table 1-2: Forest Laboratories Inc. - Ticker Codes at various Stock Exchanges
Table 1-3: Forest Laboratories Inc. - Key Management People
Table 3-1: Forest Laboratories Inc. - Financial Overview (Million US$), FY 2010
Table 3-2: Forest Laboratories Inc. - Breakup of Revenue & Sales (Million US$), FY 2008 to FY 2010
Table 3-3: Forest Laboratories Inc. - Key Financial Ratios (FY 2008 to FY 2010)
Table 3-4: Forest Laboratories Inc. - Earning & Income Estimates (Million US$), FY 2008 to FY 2010
Table 5-1: Novo Nordisk A/S - Key Financials (Million US$), 2008-2010
Table 5-2: Novo Nordisk A/S - SWOT Analysis
Table 5-3: GlaxoSmithKline - Key Financials (Million US$), 2007-2009
Table 5-4: GlaxoSmithKline - SWOT Analysis
Table 5-5: Eli Lilly & Company - Key Financials (Million US$), 2008-2010
Table 5-6: Eli Lilly & Company - SWOT Analysis

List of Charts

Figure 2-1: Forest Laboratories Inc. - Net Sales by Geographical Distribution (Million US$), FY 2009 & FY 2010
Figure 2-2: Forest Laboratories, Inc. - Net Sales by Product (%), FY 2010
Figure 3-1: Forest Laboratories, Inc. - Stock Chart

- Novo Nordisk A/S
- GlaxoSmithKline
- Eli Lilly & Company

Note: Product cover images may vary from those shown

RELATED PRODUCTS